Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection

被引:13
作者
Shamputa, Isdore Chola
Van Deun, Armand
Salim, Abdul Hamid
Hossain, Anwar
Fissette, Krista
de Rijk, Pim
Rigouts, Leen
Portaels, Francoise
机构
[1] Inst Trop Med Prince Leopold, Mycobacteriol Unit, B-2000 Antwerp, Belgium
[2] Damien Fdn Bangladesh, Dhaka, Bangladesh
[3] Trop Dis Res Ctr, Dept Biomed Sci, Ndola, Zambia
关键词
tuberculosis; reinfection; reactivation; treatment failure; DNA fingerprinting;
D O I
10.1111/j.1365-3156.2007.01840.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To determine the relative frequencies of reinfection vs. reactivation or treatment failure in patients from a high tuberculosis incidence setting with a low prevalence of HIV infection. Method We performed DNA fingerprinting on serial isolates from one and multiple TB episodes from 97 retreatment patients; 35 patients had been previously cured, whereas 62 had not. Results DNA fingerprinting patterns of recurrence Mycobacterium tuberculosis isolates of 5 of the 35 previously cured patients did not match with those of the corresponding initial isolates, indicating reinfection. We did not document reinfection during treatment. Isolates from each of the remaining 30 previously cured patients had identical DNA fingerprinting results, indicating reactivation. DNA fingerprinting patterns of isolates from the 62 patients with persistently positive sputum smears were identical, suggesting treatment failure. Conclusion These findings suggest that reinfection is not a common cause of relapse and treatment failure in this rural predominantly HIV-free population despite the high incidence of TB.
引用
收藏
页码:700 / 708
页数:9
相关论文
共 30 条
  • [21] Diagnosis and treatment outcomes of adult tuberculosis in an urban setting with high HIV prevalence in Sierra Leone: A retrospective study
    Lakoh, Sulaiman
    Jiba, Darlinda F.
    Adekanmbi, Olukemi
    Poveda, Eva
    Sahr, Foday
    Deen, Gibrilla F.
    Foray, Lynda M.
    Gashau, Wadzani
    Hoffmann, Christopher J.
    Salata, Robert A.
    Yendewa, George A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 112 - 118
  • [22] Xpert MTB/RIF Testing in a Low Tuberculosis Incidence, High-Resource Setting: Limitations in Accuracy and Clinical Impact
    Sohn, Hojoon
    Aero, Abebech D.
    Menzies, Dick
    Behr, Marcel
    Schwartzman, Kevin
    Alvarez, Gonzalo G.
    Dan, Andrei
    McIntosh, Fiona
    Pai, Madhukar
    Denkinger, Claudia M.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (07) : 970 - 976
  • [23] Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London
    Burman, Matthew
    Loutet, Miranda
    Trathan, Duncan
    Dart, Susan
    Jayasekera, Nivenka
    Tiberi, Simon
    Kunst, Heinke
    Zenner, Dominik
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [24] Real-world clinical utility of Xpert MTB/RIF Ultra in the assessment of tuberculosis in a low-TB-incidence, high-resource setting
    Kim, Jee Whang
    Patel, Hemu
    Halliwell, Richard
    Free, Robert C.
    Glimour-Caunt, Alison
    Pareek, Manish
    Woltmann, Gerrit
    Verma, Raman
    Perera, Nelun
    Haldar, Pranabashis
    BMJ OPEN RESPIRATORY RESEARCH, 2025, 12 (01)
  • [25] Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
    Schnippel, Kathryn
    Berhanu, Rebecca H.
    Black, Andrew
    Firnhaber, Cynthia
    Maitisa, Norah
    Evans, Denise
    Sinanovic, Edina
    BMC INFECTIOUS DISEASES, 2016, 16
  • [26] Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
    Kathryn Schnippel
    Rebecca H. Berhanu
    Andrew Black
    Cynthia Firnhaber
    Norah Maitisa
    Denise Evans
    Edina Sinanovic
    BMC Infectious Diseases, 16
  • [27] Feasibility of commercial interferon-γ-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guerin vaccination coverage
    Tuuminen, T.
    Sorva, S.
    Liippo, K.
    Vasankari, T.
    Soini, H.
    Eriksen-Neuman, B.
    Miettinen, A.
    Seppala, I. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (08) : 836 - 838
  • [28] Bundling HIV and TB Care at a District-Level Center in Sierra Leone: A high-yield method for diagnosing co-infection with TB and antiretroviral treatment failure among people living with HIV
    Oxner, Asa
    Kongpakpaisarn, Kullatham
    Hudey, Stephanie
    Myers, Andrew
    Sesay, John Martin
    Thomas, John Bawel
    Daboh, Fodei
    Kabba, Alpha
    Fillie, Admire
    Kainessie, Aminata Tina
    Abdulai, Tamba S.
    Elliott, Eric
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 82 : 124 - 128
  • [29] Program-wide review and follow-up of erythema Induratum of Bazin and tuberculosis-associated ocular inflammation management in a TB low-incidence setting: need for improved treatment candidate selection, therapy standardization, and care collaboration
    William J. Connors
    Dina A. Fisher
    Dennis Y. Kunimoto
    Julie M. Jarand
    BMC Infectious Diseases, 19
  • [30] Program-wide review and follow-up of erythema Induratum of Bazin and tuberculosis-associated ocular inflammation management in a TB low-incidence setting: need for improved treatment candidate selection, therapy standardization, and care collaboration
    Connors, William J.
    Fisher, Dina A.
    Kunimoto, Dennis Y.
    Jarand, Julie M.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)